Prednisone and methotrexate treat autoimmune diseases, but they do so through very different mechanisms.
Prednisone: A Powerful Anti-inflammatory
Prednisone is a glucocorticoid, a type of steroid hormone. It acts by binding to glucocorticoid receptors inside cells. This binding triggers a cascade of effects, primarily reducing inflammation. Specifically, prednisone:
- Inhibits the production of inflammatory molecules like cytokines (e. g., TNF-α, IL-1). Decreases the number of immune cells (like lymphocytes) at sites of inflammation. Reduces the expression of adhesion molecules, which helps prevent immune cells from entering inflamed tissues.
This potent anti-inflammatory action makes it highly effective for quickly reducing symptoms in conditions like rheumatoid arthritis and lupus.
Methotrexate: A Folic Acid Antagonist
Methotrexate operates quite differently. It’s an antimetabolite that interferes with folate metabolism, a process crucial for DNA synthesis and cell division. This means it disrupts the rapid proliferation of cells, particularly immune cells. Key actions include:
Inhibition of dihydrofolate reductase (DHFR), an enzyme vital for folate metabolism. This slows down DNA replication and cell division. Indirect reduction of inflammatory cytokine production. Potential modulation of the immune system’s T-cell response, potentially contributing to long-term disease modification.
Unlike prednisone’s fast-acting anti-inflammatory effects, methotrexate’s effects on inflammation are more gradual, often taking weeks to become noticeable. However, its impact on disease progression can be more sustained.
